Financings In Brief: DepoTech
Executive Summary
DepoTech: Drug delivery system R&D firm files registration with the Securities & Exchange Commission for initial public offering of 2.5 mil. shares of common stock at an estimated per share price of $10-$12, La Jolla, Calif.-based company reports Aug. 23. Dillon, Read and UBS Securities are managing the offering. Following the IPO, DepoTech will have approximately 10.3 mil. shares outstanding, assuming no over-allotment. The underwriters have an option to purchase 375,000 shares...